GABA Receptors in Neuronal Inhibition

GABA Receptors in Neuronal Inhibition

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">GABA Receptors in Neuronal Inhibition</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:4042028](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4042028)</td>
</tr>
<tr>
<td class="label">Study</td>
<td>Key Finding</td>
</tr>
<tr>
<td class="label">GABA loss in AD</td>
<td>Reduced interneurons correlate with cognitive decline</td>
</tr>
<tr>
<td class="label">Network dynamics</td>
<td>GABAergic modulation restores gamma oscillations</td>
</tr>
<tr>
<td class="label">Therapeutic potential</td>
<td>GABA_B agonism protects dopaminergic neurons</td>
</tr>
</table>

Gaba Receptors In Neuronal Inhibition is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

GABA is the primary inhibitory neurotransmitter in the CNS. Its receptors mediate inhibition and are dysregulated in neurodegeneration. [@sieghart2002]

Overview

GABA Receptors in Neuronal Inhibition

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">GABA Receptors in Neuronal Inhibition</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:4042028](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4042028)</td>
</tr>
<tr>
<td class="label">Study</td>
<td>Key Finding</td>
</tr>
<tr>
<td class="label">GABA loss in AD</td>
<td>Reduced interneurons correlate with cognitive decline</td>
</tr>
<tr>
<td class="label">Network dynamics</td>
<td>GABAergic modulation restores gamma oscillations</td>
</tr>
<tr>
<td class="label">Therapeutic potential</td>
<td>GABA_B agonism protects dopaminergic neurons</td>
</tr>
</table>

Gaba Receptors In Neuronal Inhibition is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

GABA is the primary inhibitory neurotransmitter in the CNS. Its receptors mediate inhibition and are dysregulated in neurodegeneration. [@sieghart2002]

Overview

GABA_A Receptors

• Ligand-gated chloride channel: Fast inhibition
• Subunits: α1-6, β1-3, γ1-3, δ, π, ρ
• Location: Synaptic and extrasynaptic
• Benzodiazepine site: Allosteric modulator

GABA_B Receptors

• Metabotropic: G protein-coupled
• Presynaptic: Inhibit release
• Postsynaptic: Hyperpolarization
• Kainate modulation: Cross-talk

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

• Morphology: immature neuron (source: Cell Ontology)
• Morphology can be inferred from Cell Ontology classification

External Database Links

• [Cell Ontology (CL:4042028)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4042028)
• [OBO Foundry (CL:4042028)](http://purl.obolibrary.org/obo/CL_4042028)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)

Function

Neurodegeneration Relevance

Alzheimer's Disease

• GABAergic loss: Reduced interneurons
• Network dysfunction: Hyperexcitability
• Seizures: Comorbidity

Parkinson's Disease

• Inhibition changes: Basal ganglia circuits
• DBS mechanisms: GABAergic modulation

Key Publications

• Sieghart W, Sperk G. (2002). Subunit composition, distribution and function of GABA-A receptor subtypes. Curr Top Med Chem. [DOI:10.2174/1568026023393507](https://doi.org/10.2174/1568026023393507)

Background

The study of Gaba Receptors In Neuronal Inhibition has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development. [@cherubini2001]

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions. [@mhler2006]

Additional evidence sources: [@farrant2005] [@whiting2003] [@rudolph2004] [@jacob2008]

References

[@bormann2000]: Bormann J. (2000). The ABC of GABA receptors. Trends Pharmacol Sci. PMID: 10650358(https://pubmed.ncbi.nlm.nih.gov/10650358/). https://pubmed.ncbi.nlm.nih.gov/10650358/
[@sieghart2002]: Sieghart W, Sperk G. (2002). Subunit composition, distribution and function of GABA-A receptor subtypes. Curr Top Med Chem. PMID: 11945129(https://pubmed.ncbi.nlm.nih.gov/11945129/). https://pubmed.ncbi.nlm.nih.gov/11945129/
[@cherubini2001]: Cherubini E, Conti F. (2001). Generating diversity at GABAergic synapses. Trends Neurosci. PMID: 11515195(https://pubmed.ncbi.nlm.nih.gov/11515195/). https://pubmed.ncbi.nlm.nih.gov/11515195/
[@mhler2006]: Möhler H. (2006). GABAergic neurons: decoding the logic of inhibitory circuits. Brain Res. PMID: 16524597(https://pubmed.ncbi.nlm.nih.gov/16524597/). https://pubmed.ncbi.nih/16524597/
[@farrant2005]: Farrant M, Nusser Z. (2005). Variations on an inhibitory theme: phasic and tonic activation of GABA_A receptors. Nat Rev Neurosci. PMID: 15821740(https://pubmed.ncbi.nlm.nih.gov/15821740/). https://pubmed.ncbi.nlm.nih.gov/15821740/
[@whiting2003]: Whiting PJ. (2003). GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery? Drug Discov Today. PMID: 14519162(https://pubmed.ncbi.nlm.nih.gov/14519162/). https://pubmed.ncbi.nlm.nih.gov/14519162/
[@rudolph2004]: Rudolph U, Möhler H. (2004). GABA-based therapeutic approaches: GABA_A receptor subtype functions. Curr Opin Pharmacol. PMID: 14602450(https://pubmed.ncbi.nlm.nih.gov/14602450/). https://pubmed.ncbi.nlm.nih.gov/14602450/
[@jacob2008]: Jacob TC, Moss SJ, Jurd R. (2008). GABA(A) receptor trafficking and the molecular pathology of epilepsy. Neuropharmacology. PMID: 17928081(https://pubmed.ncbi.nlm.nih.gov/17928081/). https://pubmed.ncbi.nlm.nih.gov/17928081/

• [GABAergic Neurons](/cell-types/gabaergic-neurons)
• [Excitotoxicity](/mechanisms/excitotoxicity)

External Links

• [GABA Receptors (Nature)](https://www.nature.com/subjects/gaba-receptors)

Receptor Subtypes in Detail

GABA_A Receptor Structure

• Pentameric assembly: Typically 2α, 2β, 1γ or δ
• α1-containing: Sedative effects, motor coordination
• α2-containing: Anxiolytic, analgesic effects
• α5-containing: Memory, hippocampal function

GABA_B Receptor Signaling

• GPCR mechanism: Gi/o protein coupled
• Presynaptic: Inhibit Ca2+ channels, reduce release
• Postsynaptic: Activate K+ channels, hyperpolarize
• Metabotropic effects: Slower, prolonged inhibition

Pathophysiology in Neurodegeneration

Synaptic Plasticity Impairment

• LTP disruption: GABAergic inhibition affects memory
• Inhibitory plasticity: Altered in AD models
• Homeostatic scaling: Compensation attempts fail

Network Hyperexcitability

Therapeutic Targeting

Current Approaches

• Benzodiazepines: Positive allosteric modulators
• Baclofen: GABA_B agonist (spasticity)
• Tiagabine: GABA transporter inhibitor

Emerging Strategies

• Subunit-selective: α5 inverse agonists
• Receptor internalization: Modulation strategies
• Gene therapy: GAD delivery approaches

Key Research Findings

References

Pathway Diagram

The following diagram shows the key molecular relationships involving GABA Receptors in Neuronal Inhibition discovered through SciDEX knowledge graph analysis: